Clinical trial
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
NCT00427336 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00427336 |
|---|---|
| Title | Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia |
| Official title | Purine Analog-Based Conditioning for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Drug |
| Interventions | Fludarabine, Cyclophosphamide, Antithymocyte Globulin |
| Enrollment | 9 |
| Start date | Dec 1, 2000 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jan 29, 2007 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: